Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III...

Keywords

CapecitabineMedicineCisplatinFluorouracilInternal medicineOncologyCancerChemotherapyColorectal cancer

Affiliated Institutions

Related Publications

Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group

Eric Van Cutsem , Vladimir Moiseyenko , Sergei Tjulandin +9 more

Purpose In the randomized, multinational phase II/III trial (V325) of untreated advanced gastric cancer patients, the phase II part selected docetaxel, cisplatin, and fluorourac...

2006 Journal of Clinical Oncology 1912 citations

Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis Based on Aggregate Data

Dorothea Wagner , Wilfried Grothe , Johannes Haerting +3 more

Purpose This systematic review and meta-analysis were performed to assess the efficacy and tolerability of chemotherapy in patients with advanced gastric cancer. Methods Randomi...

2006 Journal of Clinical Oncology 1179 citations

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial

Yelena Y. Janjigian , Kohei Shitara , Markus Moehler +26 more

First-line chemotherapy for advanced or metastatic human epidermal growth factor receptor 2 (HER2)-negative gastric or gastro-oesophageal junction adenocarcinoma has a median ov...

2021 The Lancet 2580 citations

Historical Evolution of Second-Line Therapy in Non-Small Cell Lung Cancer

Chiara Lazzari , Alessandra Bulotta , Monika Ducceschi +5 more

Innovative therapeutic agents have significantly improved outcome with an acceptable safety profile in a substantial proportion of non-small cell lung cancer (NSCLC) patients, w...

2017 Frontiers in Medicine 36 citations

Phase III Trial of Gemcitabine Plus Cisplatin Versus Cisplatin Alone in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

Alan B. Sandler , John Nemunaitis , Claude Denham +10 more

PURPOSE: The Hoosier Oncology Group has previously reported the results of its phase II trial of the combination of cisplatin plus gemcitabine. In that study of 27 assessable pa...

2000 Journal of Clinical Oncology 716 citations

Publication Info

Year: 2009
Type: article
Volume: 20
Issue: 4
Pages: 666-673
Citations: 766
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

766

OpenAlex

Cite This

APA Style

                            
                                
                                    Yoon‐Koo Kang, 
                                
                                    Won Ki Kang, 
                                
                                    D.B. Shin
                                
                                et al.
                            
                            (2009). 
                            Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial. 
                            Annals of Oncology
                            , 20
                            (4)
                            , 666-673.
                            https://doi.org/10.1093/annonc/mdn717
                        

Identifiers

DOI: 10.1093/annonc/mdn717